Article

Musashi-2 (MSI2) regulation of DNA damage response in lung cancer

2024-04-11

Abstract excerpt

<title>Abstract</title> <p> Lung cancer is one of the most common types of cancer worldwide. Non-small cell lung cancer (NSCLC), typically caused by <italic>KRAS</italic> and <italic>TP53</italic> driver mutations, represents the majority of all new lung cancer diagnoses. Overexpression of the RNA-binding protein (RBP) Musashi-2 (MSI2) has been associated with NSCLC progression. To investigate the role of MS...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 09165f76-0bab-5b83-a2e7-22abae1986ac
DOI: 10.21203/rs.3.rs-4021568/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Musashi-2 (MSI2) regulation of DNA damage response in lung cancerDOI 10.21203/rs.3.rs-4021568/v1Read

Musashi-2 (MSI2) regulation of DNA damage response in lung cancerSemantic proximity Read

Regulation of lung cancer initiation and progression by the stem cell determinant MusashiSemantic proximity Read

SERPINE2/PN-1 regulates the DNA damage response and radioresistance by activating ATM in lung cancerSemantic proximity Read

DNA mismatch repair deficiency accelerates lung neoplasm development in K-ras(LA1/+) mice: a brief report.Semantic proximity Read

Genomic characteristics and prognosis of lung cancer patients with MSI-H: A cohort study.Semantic proximity Read

<i>ARID2</i> deficiency promotes tumor progression and is associated with higher sensitivity to PARP inhibition in lung cancerSemantic proximity Read

H2AFX modulates lung adenocarcinoma cell progression through the PPM1G-MAPK signaling axisSemantic proximity Read

Recruitment of KMT2C/MLL3 to DNA Damage Sites Mediates DNA Damage Responses and Regulates PARP Inhibitor Sensitivity in Cancer.Semantic proximity Read

NPAS2 dampens chemo-sensitivity of lung adenocarcinoma cells by enhancing DNA damage repairSemantic proximity Read

UHRF1 is a mediator of KRAS driven oncogenesis in lung adenocarcinomaSemantic proximity Read

EMSY inhibits homologous recombination repair and the interferon response, promoting lung cancer immune evasion.Semantic proximity Read

ARID2 deficiency promotes tumor progression and is associated with higher sensitivity to chemotherapy in lung cancerSemantic proximity Read